Development of miRNA-mimic nanoparticles for the treatment of brain tumours

Tools

Anithiya Ramamoorthi Gopalram, Shubaash (2017) Development of miRNA-mimic nanoparticles for the treatment of brain tumours. PhD thesis, University of Nottingham, UK and University of Angers, FR.

[thumbnail of Full Thesis - For Jury and Public] PDF (Full Thesis - For Jury and Public) (Thesis - as examined) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Available under Licence Creative Commons Attribution Non-commercial No Derivatives.
Download (15MB)
[thumbnail of Jury's Comments and Actions Taken (ONLY for Jury)] PDF (Jury's Comments and Actions Taken (ONLY for Jury)) (Thesis - as examined) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (609kB)

Abstract

Glioblastoma are aggressive brain tumours with a median survival of 15 months even with the best currently available treatment options. microRNAs (miRNA) are ~23 nucleotide natural silencing RNAs that have great potentials to improve cancer treatment outcomes. Lack of a safe, stable and efficient delivery system has, however, hindered the use of miRNAs in clinical applications. The aim is therefore to develop a miRNA delivery system adapted to glioblastoma using linear chain cationic polyamidoamine (PAA) polymers. The first part involved the development of luciferase assay that combined the measurement of gene-knockdown efficiency and cytotoxicity of miRNA nanoparticles. The simple two-step procedure was more effective and sensitive compared to the conventional protein-based normalization method. The second part was focused on the development of miRNA nanoparticles. In the initial phase, conditions required for maximum miRNA-polymer binding was achieved, however, the newly developed miRNA-PAA-nanoparticles did not produce significant functional gene-knockdown after cell treatment. The second stage was focused on the optimization of nanoparticle formulation as a function of stability in physiological ionic concentration. Stable PAA-nanoparticles displaying moderate cellular uptake and gene-knockdown were obtained. The final stage of development was focused on PAA-nanoparticle tagging with biotin, which improved their cellular uptake. This work developed simple and informative luciferase assay; the stability of miRNA-PAA-nanoparticles was improved by thiol-crosslinking and the cellular uptake was enhanced by a simple but smart method of ligand tagging. Further optimizations are needed to increase the functional performance of these potential and clinically relevant thiol-stabilized RNAi vectors.

Item Type: Thesis (University of Nottingham only) (PhD)
Supervisors: Garnett, Martin
Garcion, Emmanuel
Coyle, Beth
Keywords: miRNA Delivery, Glioblastoma, Poly(amidoamine), thiol crosslinking, ligand targeting, nanomedicine, luciferase assay, RNA interference.
Subjects: Q Science > QP Physiology > QP351 Neurophysiology and neuropsychology
Faculties/Schools: UK Campuses > Faculty of Science > School of Pharmacy
Item ID: 39449
Depositing User: Anthiya Ramamoorthi Gopalram, Shubaash
Date Deposited: 17 Jul 2017 04:40
Last Modified: 05 Jun 2018 15:58
URI: https://eprints.nottingham.ac.uk/id/eprint/39449

Actions (Archive Staff Only)

Edit View Edit View